Publications & Works

Publication Network
Articles 4
All (4)
SCI-E, SSCI, AHCI (3)
SCI-E, SSCI, AHCI, ESCI (4)
ESCI (1)
Scopus (4)
TRDizin (1)

1. Amygdala Kindling Resistance in Rats with Genetic Absence Epilepsy: Role of Sex Differences

Sariyildiz O., Erdeve E. T., Mutlu N., TURAN T. T., Yilmaz N. C., ONAT F.
ARCHIVES OF EPILEPSY , vol.31, no.2, pp.42-46, 2025 (ESCI, Scopus, TRDizin)

2. Reparixin as a Potential Antiepileptogenic Agent: Modulation of the CXCL1-CXCR1/2 Axis and Seizure Activity in a Kindling Rat Model of Temporal Lobe Epilepsy

ÇARÇAK YILMAZ N., MUTLU N., Erdeve E. T., TURAN T. T., Sariyildiz O., Ulusoy C., et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES , vol.26, no.7, 2025 (SCI-Expanded, Scopus) Sustainable Development

3. Involvement of orexin type-2 receptors in genetic absence epilepsy rats

Toplu A., Mutlu N., Erdeve E. T., SARIYILDIZ Ö., Celik M., Oz-Arslan D., et al.
FRONTIERS IN NEUROLOGY , vol.14, 2023 (SCI-Expanded, Scopus) Sustainable Development

4. Regeneration in 60-and 90-day old genetic absence epilepsy rats induced by the 6-hydroxydopamine in the medial forebrain bundle

SARIYILDIZ Ö., Asik Z. N. T., ÇULPAN Y., TOPLU A., GÜLÇEBİ İDRİZ OĞLU M., ONAT F.
EPILEPSIA , vol.63, pp.87-88, 2022 (SCI-Expanded, Scopus)
Papers Presented at Peer-Reviewed Scientific Conferences 7

1. Spatial Transcriptomics Explores Potential Epileptogenic Cell Populations in Absence Epilepsy

AYDIN E., Sevinc-Ozdemir N., Ozdemir S., EKEN Y., AKKUŞ A., MUTLU N., et al.
58th Conference of the European-Society-of-Human-Genetics (ESHG), Milan, Italy, 24 - 27 May 2025, vol.33, pp.463, (Summary Text)

2. Absans Epilepsisinin Epileptogenez Döneminde Kronik Fenitoin Uygulamasının Etkisi

Turan T. T., Erdeve E. T., Sarıyıldız Ö., Mutlu N., Aslan D., Canözer U., et al.
7. Epilepsi Sempozyumu, Sakarya, Turkey, 26 - 28 May 2023, vol.29, pp.11, (Full Text) Sustainable Development

3. Amygdala kindling resistance in genetic absence epilepsy rats: Investigating sex-difference

SARIYILDIZ Ö., Erdeve E. T., Mutlu N., TURAN T. T., Yilmaz N. C., ONAT F.
15th European Epilepsy Congress, Rome, Italy, 7 - 11 September 2024, vol.65, pp.119, (Summary Text)

4. The effect of 100 mg/kg levetiracetam in a temporal lobe epilepsy animal model

Turan T. T., Erdeve E. T., Mutlu N., Sarıyıldız Ö., Çarçak Yılmaz N., Onat F.
15th European Epilepsy Congress, Rome, Italy, 7 - 11 September 2024, vol.65, pp.970-971, (Full Text)

5. YNT-185 injection into the intracerebroventricular or thalamus, or cortex: Effects on absence epilepsy seizures

Toplu A., Mutlu N., Erdeve E. T., Sarıyıldız Ö., Çarçak Yılmaz N., Onat F.
Türk Farmakoloji Derneği, Antalya, Turkey, 23 - 26 November 2023, pp.1, (Summary Text)

6. Orexin type-2 receptors distribution in GAERS in different brain regions

Mutlu N., Açıkel Elmas M., Sevinç Özdemir N., Sarıyıldız Ö., Erdeve E. T., Çarçak Yılmaz N., et al.
GEMSTONE Project 1st Dissemination Event: Regional Symposium on Neurodevelopmental Aspects of Brain Disorders & Genetically Engineered Models, İstanbul, Turkey, 3 - 04 October 2023, pp.1, (Summary Text)

7. Regeneration in 60-and 90-day old genetic absence epilepsy rats induced by the 6-hydroxydopamine in the medial forebrain bundle

Sarıyıldız Ö., Turgan Aşık Z. N., Çulpan Y., Toplu A., Gülçebi İdriz Oğlu M., Onat F.
14. Avrupa Epilepsi Kongresi, Geneve, Switzerland, 9 - 13 July 2022, pp.1, (Summary Text)
Metrics

Publication

11

Publication (WoS)

6

Publication (Scopus)

4

Citation (WoS)

7

H-Index (WoS)

2

Citation (Scopus)

8

H-Index (Scopus)

2
UN Sustainable Development Goals
SDG 3: GOAL 3: GOOD HEALTH AND WELL-BEING